только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 4 / 6
Страница 1 / 12

Список литературы

  1. Бертрам Г. Катцунг. Базисная и клиническая фармакология. В 2 т. Пер. с англ. М.; СПб.: Бином — Невский Диалект, 1998. Т. 2.
  2. Василенко В.X., Гребнев А.Л., Шептулин А.А. Язвенная бо- лезнь (современные представления о патогенезе, диагности- ке, лечении). АМН СССР. М.: Медицина, 1987.
  3. Исаков В.А. Ингибиторы протонного насоса: их свойства и применение в гастроэнтерологии. М.: Академкнига, 2001.
  4. Литвицкий П.Ф. Патофизиология. В 2 т. М.: ГЭОТАР-МЕД, 2002. Т. 1.
  5. Литвицкий П.Ф. Патофизиология. В 2 т. М.: ГЭОТАР-МЕД, 2002. Т. 2.
  6. Патологическая физиология. Под ред. А.Д. Адо, М.А. Адо, В.И. Пыцкого и др. М.: Триада-Х, 2000.
  7. Руководство по общей патологии человека. Под ред. Н.К. Хит- рова, Д.С. Саркисова, М.А. Пальцева. М.: Медицина, 1999.
  8. Харкевич Д.А. Фармакология. М.: Медицина, 1996.
  9. Brunner G.H., Thiesemann С. The potential clinical role of intra- venous omeprazole. Digestion 1992; 51(1): 17—20.
  10. Cash B.D. Evidence-based medicine as it applies to acid suppression in the hospitalized patient. Crit. Care Med. 2002; 30 (6): 373—378.
  11. Conrad S.A. Acute upper gastrointestinal bleeding in critically ill patients: Causes and treatment modalities. Crit. Care Med. 2002; 30 (6): 365—368.
  12. Cook D.J., Fuller H.D., Guyatt G.H., et al. Risk factors for gas- trointestinal bleeding in critically ill patients: Canadian Crit. Care Trials Groups. N. Engl J Med. 1994; 330: 397—381.
  13. Cook D.J., Guyatt G., Marshall J., et al. A comparison ofsucralfate and ranitidine for the prevention of upper gastrointestinal blee- ding in patients requiring mechanical ventilation: Canadian Crit. Care Trials Group. N. Engl J Med. 1998; 338: 791—797.
  14. Cook D.J., Reeve B.K., Guyatt G.H., et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 1996; 275: 308—314.
  15. Cook D.J., Witt L.G., Cook R.J., et al. Stress ulcer prophylaxis in the critically ill: A meta-analysis. Am. J Med. 1991; 91: 519—527.
  16. Fennerty M.B. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: Rationale for therapeutic benefits of acid suppression. Crit. Care Med. 2002; 30 (6): 351—355.
  17. Geus W.P. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding? Scand. J Gastroenterol. 2000; 232: 10—20.
  18. Geus W.P., Lamers C.B. Intravenous gastric acid inhibition for stress ulcers and bleeding peptic ulcers. Ned. Tijdschr. Geneeskd. 1999; 143 (50): 2514—2518.
  19. Heyland D., Griffith L., Cook D.J., et al. The clinical and economic consequences of clinically important gastrointestinal bleeding in the critically ill. Crit. Care Med. 1995; 23: 108.
  20. Lanas A., Artal A., Bias J., et al. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J Clin. Gastroenterol. 1995; 21 (2): 103—106.
  21. Lasky M.R., Metzler M.H., Phillips J.O. A prospective study of omeprazole suspension to prevent clinically significant gastroin- testinal bleeding from stress ulcers in mechanically ventilated trauma patients. J. Trauma. 1998; 44 (3): 527—533.
  22. Laterre P.F., Horsmans Y. Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pH. Crit. Care Med. 2001; 29 (10): 1931—1935.
  23. Levy M.J., Seelig C.B., Robinson N.J., Ranney J.E. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig. Dis. Sci. 1997; 42 (6): 1255—1259.
  24. Merki H.S., Wilder-Smith C.H. Do continuous infusions of omepra- zole and ranitidine retain their effect with prolonged dosing? Gastroenterology 1994; 106 (1): 60—64.
  25. Raynard В., Nitenberg G. Is prevention of upper digestive system hemorrhage in intensive care necessary? Schweiz. Med. Wochenschr. 1999; 129 (43): 1605—1612.
  26. Schuster D.R., Rowley H., Feinstein S., et al. Prospective evalua- tion of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Amer. J Med. 1984; 76 (4): 623— 630.
  27. Simoens M., Gevers A.M., Rutgeerte P. Endoscopic therapy for upper gastrointestinal hemorrhage: A state of the art. Hepatoga- stroenterology 1999; 46: 737—745.
  28. Tryba M. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: A meta-analysis on efficacy and pneumonia rate. Crit. Care Med. 1991; 19: 942—949.
  29. Warzecha Z., Dembinski A., Brzozowski Т., et al. Histamine in stress ulcer prophylaxis in rats. J. Physiol. Pharma.